SCHEMBL9750418

SCHEMBL9750418

COC(=O)CCc1nsnc1OCC(O)CNCCNC(=O)c1cc2ccccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 2/20 0.42
DRD2 P14416 1/20 0.42
HTR2C P28335 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HRH4 Q9H3N8 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTR1A P08908 1/20 0.40
DRD4 P21917 1/20 0.40
AKR1C3 P42330 1/20 0.39
HDAC1 Q13547 3/20 0.39
HDAC2 Q92769 3/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10979580 0.93 DRD2 (0.42) DRD3DRD2HTR2CKDM4EALDH1A1
SCHEMBL9749280 0.85 DRD3 (0.41) DRD3DRD2HTR2CMTNR1AMTNR1B
SCHEMBL9749960 0.84 ADRB1 (0.48)
SCHEMBL9750398 0.82 DRD2 (0.39) DRD3DRD2HTR2CKDM4EALDH1A1
SCHEMBL9750393 0.80 DRD3 (0.42) DRD3DRD2HTR2CMTNR1AMTNR1B
SCHEMBL10980083 0.79 ADRB1 (0.45) HTR2CKDM4EALDH1A1
SCHEMBL10460530 0.79 ADRB2 (0.36)
SCHEMBL10993319 0.77 ADRB2 (0.41)
SCHEMBL9750379 0.77 ADRB2 (0.46)
SCHEMBL9749808 0.76 HTR4 (0.42) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP disclosed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US disclosed